InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,115.94
(
-2.03%
)
Post# of 252503
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119984
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ciotera post# 246988

Tuesday, 05/16/2023 3:24:12 PM

Tuesday, May 16, 2023 3:24:12 PM

Post# of 252503

…AbbVie got rid of [Atrasentan]…

More or less; this is the 2020 PR announcing the ABBV-Chinook Atrasentan deal:

https://www.businesswire.com/news/home/20200110005075/en/Chinook-Therapeutics-Obtains-Worldwide-Rights-from-AbbVie-to-Atrasentan-with-Plans-to-Develop-for-the-Treatment-of-Kidney-Diseases

Under the terms of the license agreement, Chinook obtains worldwide rights to all fields of use for atrasentan and assumes full responsibility for advancing the program going forward. AbbVie will receive an undisclosed upfront cash payment, potential future milestones and royalties, and an equity stake in Chinook.

This PR wasn’t posted on the message board because Chinook hadn’t yet gone public via the reverse-merger with ADRO (#msg-158654033).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up